Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT
Go back to Arrowhead Pharmaceuticals Receives Orphan Drug Designation for ARO-AAT| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 87.90 -0.8 (0.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $88.70 | 52 Week High | $8.22 | |||
| Open | $87.72 | 52 Week Low | $3.07 | |||
| Day High | $88.35 | P/E | N/A | |||
| Day Low | $85.98 | EPS | $-1.30 | |||
| Volume | 972,092 | |||||
